Michael D Hogarty (Michael Hogarty)

ORCID

Publication Activity (10 Years)

Years Active: 2020-2024
Publications (10 Years): 29

Top Venues

Cancer

British journal of cancer

Journal of clinical oncology : official journal of the American Society of Clinical Oncology

Clinical cancer research : an official journal of the American Association for Cancer Research

This page only lists publications with an associated author ORCID identifier.

Publications

Kevin Bielamowicz, Peter Dimitrion, Oussama Abla, Simon Bomken, Patrick Campbell, Matthew Collin, Barbara Degar, Eli L Diamond, Olive S Eckstein, Nader El-Mallawany, Mark Fluchel, Gaurav Goyal, Michael M Henry, Michelle L Hermiston, Michael D Hogarty, Michael Jeng, Rima Jubran, Joseph Lubega, Ashish Kumar, Stephan Ladisch, Kenneth L McClain, Miriam Merad, Qing-Sheng Mi, D Williams Parsons, Erin Peckham-Gregory, Jennifer Picarsic, Zachary D Prudowsky, Barrett J Rollins, Peter H Shaw, Birte Wistinghausen, Carlos Rodriguez-Galindo, Carl E Allen, null null
Langerhans cell histiocytosis: NACHO update on progress, chaos, and opportunity on the path to rational cures. Cancer 130 (14) (2024)
Sarah Cherkaoui, Lifeng Yang, Matthew J McBride, Christina S Turn, Wenyun Lu, Caroline Eigenmann, George E Allen, Olesya O Panasenko, Lu Zhang, Annette Vu, Kangning Liu, Yimei Li, Om H Gandhi, Lea Surrey, Michael Wierer, Eileen P White, Joshua D Rabinowitz, Michael D Hogarty, Raphael J Morscher
Reprogramming neuroblastoma by diet-enhanced polyamine depletion. bioRxiv : the preprint server for biology (2024)
Kevin Bielamowicz, Peter Dimitrion, Oussama Abla, Simon Bomken, Patrick Campbell, Matthew Collin, Barbara Degar, Eli L Diamond, Olive S Eckstein, Nader El-Mallawany, Mark Fluchel, Gaurav Goyal, Michael M Henry, Michelle L Hermiston, Michael D Hogarty, Michael Jeng, Rima Jubran, Joseph Lubega, Ashish Kumar, Stephan Ladisch, Kenneth L McClain, Miriam Merad, Qing-Sheng Mi, D Williams Parsons, Erin Peckham-Gregory, Jennifer Picarsic, Zachary D Prudowsky, Barrett J Rollins, Peter H Shaw, Birte Wistinghausen, Carlos Rodriguez-Galindo, Carl E Allen, null null
Langerhans cell histiocytosis: NACHO update on progress, chaos, and opportunity on the path to rational cures. Cancer 130 (14) (2024)
Michael D Hogarty, David S Ziegler, Andrea T Flynn, Yueh-Yun Chi, Denice Tsao-Wei, Kangning Liu, Rohan Vemu, Eugene W Gerner, Elizabeth Bruckheimer, Anasheh Shamirian, Beth Hasenauer, Frank M Balis, Susan Groshen, Murray D Norris, Michelle Haber, Julie R Park, Katherine K Matthay, Araz Marachelian
Phase 1 study of high-dose DFMO, celecoxib, cyclophosphamide and topotecan for patients with relapsed neuroblastoma: a New Approaches to Neuroblastoma Therapy trial. British journal of cancer 130 (5) (2024)
Michael D Hogarty, David S Ziegler, Andrea T Flynn, Yueh-Yun Chi, Denice Tsao-Wei, Kangning Liu, Rohan Vemu, Eugene W Gerner, Elizabeth Bruckheimer, Anasheh Shamirian, Beth Hasenauer, Frank M Balis, Susan Groshen, Murray D Norris, Michelle Haber, Julie R Park, Katherine K Matthay, Araz Marachelian
Phase 1 study of high-dose DFMO, celecoxib, cyclophosphamide and topotecan for patients with relapsed neuroblastoma: a New Approaches to Neuroblastoma Therapy trial. British journal of cancer 130 (5) (2024)
Kevin Bielamowicz, Peter Dimitrion, Oussama Abla, Simon Bomken, Patrick Campbell, Matthew Collin, Barbara Degar, Eli L Diamond, Olive S Eckstein, Nader El-Mallawany, Mark Fluchel, Gaurav Goyal, Michael M Henry, Michelle L Hermiston, Michael D Hogarty, Michael Jeng, Rima Jubran, Joseph Lubega, Ashish Kumar, Stephan Ladisch, Kenneth L McClain, Miriam Merad, Qing-Sheng Mi, D Williams Parsons, Erin Peckham-Gregory, Jennifer Picarsic, Zachary D Prudowsky, Barrett J Rollins, Peter H Shaw, Birte Wistinghausen, Carlos Rodriguez-Galindo, Carl E Allen, null null
Langerhans cell histiocytosis: NACHO update on progress, chaos, and opportunity on the path to rational cures. Cancer 130 (14) (2024)
Michael D Hogarty, David S Ziegler, Andrea T Flynn, Yueh-Yun Chi, Denice Tsao-Wei, Kangning Liu, Rohan Vemu, Eugene W Gerner, Elizabeth Bruckheimer, Anasheh Shamirian, Beth Hasenauer, Frank M Balis, Susan Groshen, Murray D Norris, Michelle Haber, Julie R Park, Katherine K Matthay, Araz Marachelian
Phase 1 study of high-dose DFMO, celecoxib, cyclophosphamide and topotecan for patients with relapsed neuroblastoma: a New Approaches to Neuroblastoma Therapy trial. British journal of cancer 130 (5) (2024)
Sarah Cherkaoui, Lifeng Yang, Matthew J McBride, Christina S Turn, Wenyun Lu, Caroline Eigenmann, George E Allen, Olesya O Panasenko, Lu Zhang, Annette Vu, Kangning Liu, Yimei Li, Om H Gandhi, Lea Surrey, Michael Wierer, Eileen P White, Joshua D Rabinowitz, Michael D Hogarty, Raphael J Morscher
Reprogramming neuroblastoma by diet-enhanced polyamine depletion. bioRxiv : the preprint server for biology (2024)
Kevin Bielamowicz, Peter Dimitrion, Oussama Abla, Simon Bomken, Patrick Campbell, Matthew Collin, Barbara Degar, Eli L Diamond, Olive S Eckstein, Nader El-Mallawany, Mark Fluchel, Gaurav Goyal, Michael M Henry, Michelle L Hermiston, Michael D Hogarty, Michael Jeng, Rima Jubran, Joseph Lubega, Ashish Kumar, Stephan Ladisch, Kenneth L McClain, Miriam Merad, Qing-Sheng Mi, D Williams Parsons, Erin Peckham-Gregory, Jennifer Picarsic, Zachary D Prudowsky, Barrett J Rollins, Peter H Shaw, Birte Wistinghausen, Carlos Rodriguez-Galindo, Carl E Allen, null null
Langerhans cell histiocytosis: NACHO update on progress, chaos, and opportunity on the path to rational cures. Cancer (2024)
Michael D Hogarty, David S Ziegler, Andrea T Flynn, Yueh-Yun Chi, Denice Tsao-Wei, Kangning Liu, Rohan Vemu, Eugene W Gerner, Elizabeth Bruckheimer, Anasheh Shamirian, Beth Hasenauer, Frank M Balis, Susan Groshen, Murray D Norris, Michelle Haber, Julie R Park, Katherine K Matthay, Araz Marachelian
Phase 1 study of high-dose DFMO, celecoxib, cyclophosphamide and topotecan for patients with relapsed neuroblastoma: a New Approaches to Neuroblastoma Therapy trial. British journal of cancer 130 (5) (2024)
Michael D Hogarty, David S Ziegler, Andrea T Flynn, Yueh-Yun Chi, Denice Tsao-Wei, Kangning Liu, Rohan Vemu, Eugene W Gerner, Elizabeth Bruckheimer, Anasheh Shamirian, Beth Hasenauer, Frank M Balis, Susan Groshen, Murray D Norris, Michelle Haber, Julie R Park, Katherine K Matthay, Araz Marachelian
Phase 1 study of high-dose DFMO, celecoxib, cyclophosphamide and topotecan for patients with relapsed neuroblastoma: a New Approaches to Neuroblastoma Therapy trial. British journal of cancer (2024)
Michael D Hogarty, David S Ziegler, Andrea T Flynn, Yueh-Yun Chi, Denice Tsao-Wei, Kangning Liu, Rohan Vemu, Eugene W Gerner, Elizabeth Bruckheimer, Anasheh Shamirian, Beth Hasenauer, Frank M Balis, Susan Groshen, Murray D Norris, Michelle Haber, Julie R Park, Katherine K Matthay, Araz Marachelian
Phase 1 study of high-dose DFMO, celecoxib, cyclophosphamide and topotecan for patients with relapsed neuroblastoma: a New Approaches to Neuroblastoma Therapy trial. British journal of cancer 130 (5) (2024)
Kevin Bielamowicz, Peter Dimitrion, Oussama Abla, Simon Bomken, Patrick Campbell, Matthew Collin, Barbara Degar, Eli L Diamond, Olive S Eckstein, Nader El-Mallawany, Mark Fluchel, Gaurav Goyal, Michael M Henry, Michelle L Hermiston, Michael D Hogarty, Michael Jeng, Rima Jubran, Joseph Lubega, Ashish Kumar, Stephan Ladisch, Kenneth L McClain, Miriam Merad, Qing-Sheng Mi, D Williams Parsons, Erin Peckham-Gregory, Jennifer Picarsic, Zachary D Prudowsky, Barrett J Rollins, Peter H Shaw, Birte Wistinghausen, Carlos Rodriguez-Galindo, Carl E Allen, null null
Langerhans cell histiocytosis: NACHO update on progress, chaos, and opportunity on the path to rational cures. Cancer 130 (14) (2024)
Kevin Bielamowicz, Peter Dimitrion, Oussama Abla, Simon Bomken, Patrick Campbell, Matthew Collin, Barbara Degar, Eli L Diamond, Olive S Eckstein, Nader El-Mallawany, Mark Fluchel, Gaurav Goyal, Michael M Henry, Michelle L Hermiston, Michael D Hogarty, Michael Jeng, Rima Jubran, Joseph Lubega, Ashish Kumar, Stephan Ladisch, Kenneth L McClain, Miriam Merad, Qing-Sheng Mi, D Williams Parsons, Erin Peckham-Gregory, Jennifer Picarsic, Zachary D Prudowsky, Barrett J Rollins, Peter H Shaw, Birte Wistinghausen, Carlos Rodriguez-Galindo, Carl E Allen, null null
Langerhans cell histiocytosis: NACHO update on progress, chaos, and opportunity on the path to rational cures. Cancer (2024)
Kevin Bielamowicz, Peter Dimitrion, Oussama Abla, Simon Bomken, Patrick Campbell, Matthew Collin, Barbara Degar, Eli L Diamond, Olive S Eckstein, Nader El-Mallawany, Mark Fluchel, Gaurav Goyal, Michael M Henry, Michelle L Hermiston, Michael D Hogarty, Michael Jeng, Rima Jubran, Joseph Lubega, Ashish Kumar, Stephan Ladisch, Kenneth L McClain, Miriam Merad, Qing-Sheng Mi, D Williams Parsons, Erin Peckham-Gregory, Jennifer Picarsic, Zachary D Prudowsky, Barrett J Rollins, Peter H Shaw, Birte Wistinghausen, Carlos Rodriguez-Galindo, Carl E Allen, null null
Langerhans cell histiocytosis: NACHO update on progress, chaos, and opportunity on the path to rational cures. Cancer (2024)
Hannah G Bender, Meredith S Irwin, Michael D Hogarty, Robert Castleberry, John M Maris, Pei-Chi Kao, Fan F Zhang, Arlene Naranjo, Susan L Cohn, Wendy B London
Survival of Patients With Neuroblastoma After Assignment to Reduced Therapy Because of the 12- to 18-Month Change in Age Cutoff in Children's Oncology Group Risk Stratification. Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2023)
Hannah G Bender, Meredith S Irwin, Michael D Hogarty, Robert Castleberry, John M Maris, Pei-Chi Kao, Fan F Zhang, Arlene Naranjo, Susan L Cohn, Wendy B London
Survival of Patients With Neuroblastoma After Assignment to Reduced Therapy Because of the 12- to 18-Month Change in Age Cutoff in Children's Oncology Group Risk Stratification. Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2023)
Navin R Pinto, Arlene Naranjo, Xiangming Ding, Fan F Zhang, Emily Hibbitts, Rebekah Kennedy, Rachelle Tibbetts, Shannon Wong-Michalak, David W Craig, Zarko Manojlovic, Michael D Hogarty, Susan Kreissman, Rochelle Bagatell, Meredith S Irwin, Julie R Park, Shahab Asgharzadeh
Impact of Genomic and Clinical Factors on Outcome of Children ≥18 Months of Age with Stage 3 Neuroblastoma with Unfavorable Histology without MYCN Amplification. Clinical cancer research : an official journal of the American Association for Cancer Research (2023)
Navin R Pinto, Arlene Naranjo, Xiangming Ding, Fan F Zhang, Emily Hibbitts, Rebekah Kennedy, Rachelle Tibbetts, Shannon Wong-Michalak, David W Craig, Zarko Manojlovic, Michael D Hogarty, Susan Kreissman, Rochelle Bagatell, Meredith S Irwin, Julie R Park, Shahab Asgharzadeh
Impact of Genomic and Clinical Factors on Outcome of Children ≥18 Months of Age with Stage 3 Neuroblastoma with Unfavorable Histology without MYCN Amplification. Clinical cancer research : an official journal of the American Association for Cancer Research (2023)
Navin R Pinto, Arlene Naranjo, Xiangming Ding, Fan F Zhang, Emily Hibbitts, Rebekah Kennedy, Rachelle Tibbetts, Shannon Wong-Michalak, David W Craig, Zarko Manojlovic, Michael D Hogarty, Susan Kreissman, Rochelle Bagatell, Meredith S Irwin, Julie R Park, Shahab Asgharzadeh
Impact of Genomic and Clinical Factors on Outcome of Children ≥18 Months of Age with Stage 3 Neuroblastoma with Unfavorable Histology without MYCN Amplification. Clinical cancer research : an official journal of the American Association for Cancer Research (2023)
Adam J Wolpaw, Liron D Grossmann, Jessica L Dessau, May M Dong, Bailey J Aaron, Patricia A Brafford, Darya Volgina, Guillem Pascual-Pasto, Alba Rodriguez-Garcia, Yasin Uzun, Marie Arsenian Henriksson, Daniel J Powell, Kristopher R Bosse, Andrew Kossenkov, Kai Tan, Michael D Hogarty, John M Maris, Chi Van Dang
Epigenetic state determines inflammatory sensing in neuroblastoma. Proceedings of the National Academy of Sciences of the United States of America 119 (6) (2022)
Jorida Çoku, David M Booth, Jan Skoda, Madison C Pedrotty, Jennifer Vogel, Kangning Liu, Annette Vu, Erica L Carpenter, Jamie C Ye, Michelle A Chen, Peter Dunbar, Elizabeth Scadden, Taekyung D Yun, Eiko Nakamaru-Ogiso, Estela Area-Gomez, Yimei Li, Kelly C Goldsmith, C Patrick Reynolds, György Hajnóczky, Michael D Hogarty
Reduced ER-mitochondria connectivity promotes neuroblastoma multidrug resistance. The EMBO journal 41 (8) (2022)
Meredith S Irwin, Arlene Naranjo, Fan F Zhang, Susan L Cohn, Wendy B London, Julie M Gastier-Foster, Nilsa C Ramirez, Ruthann Pfau, Shalini Reshmi, Elizabeth Wagner, Jed Nuchtern, Shahab Asgharzadeh, Hiroyuki Shimada, John M Maris, Rochelle Bagatell, Julie R Park, Michael D Hogarty
Revised Neuroblastoma Risk Classification System: A Report From the Children's Oncology Group. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 39 (29) (2021)
Payal Jain, Lea F Surrey, Joshua Straka, Pierre Russo, Richard Womer, Marilyn M Li, Phillip B Storm, Angela J Waanders, Michael D Hogarty, Adam C Resnick, Jennifer Picarsic
BRAF fusions in pediatric histiocytic neoplasms define distinct therapeutic responsiveness to RAF paradox breakers. Pediatric blood & cancer 68 (6) (2021)
Laura D Gamble, Stefania Purgato, Michelle J Henderson, Simone Di Giacomo, Amanda J Russell, Paolo Pigini, Jayne Murray, Emanuele Valli, Giorgio Milazzo, Federico Manuel Giorgi, Mark J Cowley, Lesley J Ashton, Jaydutt Bhalshankar, Gudrun Schleiermacher, Ali Rihani, Tom Van Maerken, Jo Vandesompele, Frank Speleman, Rogier Versteeg, Jan Koster, Angelika Eggert, Rosa Noguera, Raymond L Stallings, Gian Paolo Tonini, Kwun Fong, Zalman Vaksman, Sharon J Diskin, John M Maris, Wendy B London, Glenn M Marshall, David S Ziegler, Michael D Hogarty, Giovanni Perini, Murray D Norris, Michelle Haber
A G316A Polymorphism in the Ornithine Decarboxylase Gene Promoter Modulates MYCN-Driven Childhood Neuroblastoma. Cancers 13 (8) (2021)
Babak Moghimi, Sakunthala Muthugounder, Samy Jambon, Rachelle Tibbetts, Long Hung, Hamid Bassiri, Michael D Hogarty, David M Barrett, Hiroyuki Shimada, Shahab Asgharzadeh
Preclinical assessment of the efficacy and specificity of GD2-B7H3 SynNotch CAR-T in metastatic neuroblastoma. Nature communications 12 (1) (2021)
Michael D Hogarty, Stephen P Hunger
The ASPHO 2020 distinguished career award goes to Dr Garrett M. Brodeur. Pediatric blood & cancer (2020)
Samuel L Brady, Yanling Liu, Xiaotu Ma, Alexander M Gout, Kohei Hagiwara, Xin Zhou, Jian Wang, Michael Macias, Xiaolong Chen, John Easton, Heather L Mulder, Michael C Rusch, Lu Wang, Joy Nakitandwe, Shaohua Lei, Eric M Davis, Arlene Naranjo, Cheng Cheng, John M Maris, James R Downing, Nai Kong V Cheung, Michael D Hogarty, Michael A Dyer, Jinghui Zhang
Pan-neuroblastoma analysis reveals age- and signature-associated driver alterations. Nature communications 11 (1) (2020)
Lucas Moreno, Dongjing Guo, Meredith S Irwin, Frank Berthold, Michael D Hogarty, Takehiko Kamijo, Daniel A Morgenstern, Claudia Pasqualini, Shifra Ash, Ulrike Potschger, Ruth Ladenstein, Dominique Valteau-Couanet, Susan L Cohn, Andrew D J Pearson, Wendy B London
A nomogram of clinical and biologic factors to predict survival in children newly diagnosed with high-risk neuroblastoma: An International Neuroblastoma Risk Group project. Pediatric blood & cancer 68 (3) (2020)

Michael D Hogarty.css-eqlu8i{font-size:small;padding-left:4px;} (Michael Hogarty)

Publication Activity (10 Years)

Top Topics

Top Venues

Michael D Hogarty (Michael Hogarty)